Unibest 优贝德
← Back to patent-cliff list

贝美替尼

Tier C — Watch / trade

Binimetinib

Array Biopharma
Originator
2018
First approval
-
Expiry (public)
$0.2B ▲
Peak sales
化学药
Type

TargetsMEK2、MEK1

BrandMektovi、MEKTOVI、美妥维

Indications (approved)非小细胞肺癌、黑色素瘤

Regional status

US
批准上市
2018-06-27
EU
批准上市
2018-09-20
China
批准上市
2026-06-03
Japan
批准上市
2019-01-08

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 10 · Total yield /
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
BINI-00161079-72-92,3,4-trifluorobenzoic acid
BINI-002197520-71-12,3,4-trifluoro-5-nitrobenzoic acid
BINI-003284030-57-54-amino-2,3-difluoro-5-nitrobenzoic acid
BINI-004284030-58-6methyl 4-amino-2,3-difluoro-5-nitrobenzoate
BINI-005348-54-92-fluoroaniline
BINI-006606143-94-6methyl 4-amino-3-fluoro-2-((2-fluorophenyl)amino)-5-nitrobenzoate
BINI-007-methyl 4-fluoro-5-((2-fluorophenyl)amino)-1H-benzo[d]imidazole-6-carboxylate
BINI-008606143-48-0methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1H-benzo[d]imidazole-6-carboxylate
BINI-0091415559-93-1methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
BINI-0101415564-99-65-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid
BINI-011391212-29-6methyl 2-((2-fluoro-4-iodophenyl)amino)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylate
BINI-0121415559-75-95-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]imidazole-6-carboxamide
OptimisedRoute 2Steps 11 · Total yield /
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
BINI-00161079-72-92,3,4-trifluorobenzoic acid
BINI-002197520-71-12,3,4-trifluoro-5-nitrobenzoic acid
BINI-003284030-57-54-amino-2,3-difluoro-5-nitrobenzoic acid
BINI-004284030-58-6methyl 4-amino-2,3-difluoro-5-nitrobenzoate
BINI-0091415559-93-1methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
BINI-013918321-18-3methyl 2,4-diamino-3-fluoro-5-nitrobenzoate
BINI-014918321-27-4methyl 2,4,5-triamino-3-fluorobenzoate
BINI-015462-95-3diethoxymethane
BINI-016918321-20-7methyl 5-amino-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
BINI-017105931-73-5Available4-bromo-2-fluoro-1-iodobenzene
BINI-0181604812-72-7potassium 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
BINI-0191604812-73-8(5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazol-6-yl)(1H-imidazol-1-yl)methanone
BINI-0201023742-13-3O-(2-(tert-butoxy)ethyl)hydroxylamine
BINI-0211604812-71-65-((4-bromo-2-fluorophenyl)amino)-N-(2-(tert-butoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide hydrate

Frequently asked questions

What are the approved indications of Binimetinib?

Approved indications include: 非小细胞肺癌, 黑色素瘤.

When does the Binimetinib patent expire?

No public expiry year is available for Binimetinib yet; this page updates once verified.

How many synthesis routes are recorded for Binimetinib?

2 synthesis routes are recorded; the shortest is 10 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Binimetinib intermediates?

1 intermediate CAS of Binimetinib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Binimetinib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24